Skip to main content

Table 1 Antifungal susceptibility of oral Candida albicans isolates from HIV-infected patients

From: Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis

Antifungal agents Drug concentration Resistance (%) Intermediate (%) Susceptible (%)
Fluconazole (FCN) 25 μg 32 10 58
Clotrimazole (CTM) 10 μg 14 16 70
Nystatin (NY) 100 units 0 0 100
Amphotericin B (AMB) 20 μg 0 4 96
Ketoconazole (KCA) 10 μg 28 10 62
Flucytosine (FY) 1 μg 100 0 0
\